Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
10.56
-0.22 (-2.04%)
At close: Aug 13, 2025, 4:00 PM
10.62
+0.06 (0.57%)
After-hours: Aug 13, 2025, 5:37 PM EDT
Anavex Life Sciences Employees
Anavex Life Sciences had 42 employees as of September 30, 2024. The number of employees increased by 2 or 5.00% compared to the previous year.
Employees
42
Change (1Y)
2
Growth (1Y)
5.00%
Revenue / Employee
n/a
Profits / Employee
-$1,146,905
Market Cap
907.04M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
AVXL News
- 1 day ago - Anavex Life Sciences Corp. (AVXL) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - Anavex Life Sciences Reports Fiscal 2025 Third Quarter Financial Results and Provides Business Update - GlobeNewsWire
- 8 days ago - Anavex Life Sciences to Announce Fiscal 2025 Third Quarter Financial Results on Tuesday, August 12, 2025 - GlobeNewsWire
- 13 days ago - Anavex Life Sciences Announces Positive Precision Medicine Results from up to 4-Years of Oral Blarcamesine Treatment in Phase IIb/III Open-Label Extension Trial in Early Alzheimer's Disease - GlobeNewsWire
- 3 months ago - Does Anavex's Alzheimer's Drug Actually Confer Benefit? - Seeking Alpha
- 3 months ago - The Unusual Effects Of Anavex's Blarcamesine On Alzheimer's Disease (Upgrade) - Seeking Alpha
- 3 months ago - Anavex Life Sciences to Participate at Upcoming Healthcare Conferences - GlobeNewsWire
- 3 months ago - Anavex Life Sciences Corp. (AVXL) Q2 2025 Earnings Call Transcript - Seeking Alpha